ZBTB16 anticorps (PE)

N° du produit ABIN2662834

Détail du produit anti-ZBTB16 anticorps (PE)

Antigène: ZBTB16 (Zinc Finger and BTB Domain Containing 16 (ZBTB16))

Reactivité: Souris

Hôte: Hamster arménien

Clonalité: Monoclonal

Conjugué: Cet anticorp ZBTB16 est conjugé à/à la PE

Application: Flow Cytometry (FACS)

Purification: The antibody was purified by affinity chromatography and conjugated with PE under optimal conditions. The solution is free of unconjugated PE and unconjugated antibody.

Clone: 9E12

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Concentration: 0.2 mg/mL

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Protect from prolonged exposure to light. Do not freeze.

Stock: 4 °C

Stockage commentaire: The antibody solution should be stored undiluted between 2°C and 8°C.

Détails sur ZBTB16

Antigène: ZBTB16 (Zinc Finger and BTB Domain Containing 16 (ZBTB16))

Autre désignation: PLZF (ZBTB16 Produits)

Synonymes: anticorps PLZF, anticorps ZNF145, anticorps ZGC:55675, anticorps AI467657, anticorps Zfp145, anticorps lu, anticorps Lx, anticorps Plzf, anticorps Znf145, anticorps wu:fb93g12, anticorps wu:fc07c10, anticorps zbtb16, anticorps zgc:55675, anticorps zinc finger and BTB domain containing 16, anticorps zinc finger and BTB domain containing 32, anticorps zinc finger and BTB domain containing 16a, anticorps ZBTB16, anticorps ZBTB32, anticorps Zbtb16, anticorps zbtb16a

Sujet: PLZF (promyelocytic leukemia zinc finger), also known as Zbtb16, Zinc finger and BTB domain-containing protein 16, Zfp145, is a member of the BTB-POZ family of transcription factors. It was first identified in a patient with acute promyelocytic leukemia, where a reciprocal chromosomal translocation t(11,17)(q23,q21) resulted in a fusion with RARA gene encoding retinoic acid receptor alpha. Expression of this transcriptional repressor in immune cells differs between human and mouse. In humans, PLZF is expressed in CD34+ progenitor cells and in primitive multipotent hematopoietic cell lines, NK cells, γ/δ T cells, CD4+ and CD8+ T cells. It is also expressed in MR1-specific mucosal-associated invariant T cells as well as in MHC class II-restricted T cells that develop via a thymocyte-thymocyte interaction. PLZF is involved in NK cell function, cellular quiescence, and growth suppression. It also inhibits gene expression induced by retinoic acid receptor. In mice, PLZF is highly expressed in immature CD1d-resricted invariant NKT (iNKT) cells, a subset of γ/δ (Vg1.1+Vd6.3+) T cells, and non-invariant CD1d-restricted T cells. PLZF exists as a homodimer or in complex with PLZP, and has been shown to be involved in the development of NKT cells. It is also reported to be expressed in embryonic tissues, giving rise to hematopoietic progenitors.

Pathways: Positive Regulation of fat Cell Differentiation